Dr. Scott William Jarvis, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 214 Towne Center Blvd, Van Wert, OH 45891 Phone: 419-232-2077 |
News Archive
Judge Morris E. Lasker of the U.S. District Court for the District of Massachusetts has granted final approval of a $52.5 million settlement in two separate but related securities class actions against Sepracor Inc., a Massachusetts-based pharmaceutical company.
Hospitals whose infection prevention and control programs are led by a director who is board certified in infection prevention and control have significantly lower rates of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections (BSI) than those that are not led by a certified professional, according to a new study published in the March issue of the American Journal of Infection Control, the official publication of APIC - the Association for Professionals in Infection Control and Epidemiology.
A revolutionary diagnostic technique that sees under the skin sounds rooted in the realms of science fiction. But an invention akin to the Star Trek small handheld body scanner that shines light into the skin to detect early signs of heart disease and stroke could be on the market in less than two years.
In recognition of Red Ribbon Week, October 23-31, 2012, Gateway Foundation Alcohol & Drug Treatment is working to build awareness among communities regarding the dangerous health risks associated with synthetic drug use.
Researchers have identified several target molecules which are suitable for the development of new allergy drugs. The Journal of Allergy and Clinical Immunology, the most prestigious journal in the field of allergology, has recently published an extensive review article on the prospects of drug therapy for allergy. Completed in a large-scale EU project, the lead author of the review article is Professor Ilkka Harvima of the University of Eastern Finland and Kuopio University Hospital.
› Verified 3 days ago